Xconomy National

by in

Entry	Author	Date	Location
Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial	Ryan McBride	01/26/09	Boston
Targanta Gets $42M Buyout Offer From NJ Drug Firm	Ryan McBride	01/13/09	Boston
Targanta Cuts 75 Percent of Staff	Wade Roush	12/18/08	Boston
Targanta Faces New Challenges to Raise Cash After FDA Shoots Down the Firm’s Antibiotic	Ryan McBride	12/10/08	Boston
FDA Declines Approval of Targanta Antibiotic	Ryan McBride	12/09/08	Boston
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event	Ryan McBride	12/04/08	Boston
Targanta-Cubist Rivalry Brews on FDA Review of Targanta Drug	Ryan McBride	11/18/08	Boston
Targanta Releases Antibiotic Data	Ryan McBride	10/22/08	Boston
Trius Therapeutics, Developer of Antibiotic Against MRSA, Taking On Pfizer’s Zyvox	Luke Timmerman	10/20/08	San Diego
Targanta Preps For FDA Advisory Panel on New Antibiotic	Luke Timmerman	10/14/08	Boston
Targanta Aims to “Simplifi” Treatment of Deadly Bugs With Single-Shot Antibiotic	Luke Timmerman	09/22/08	Boston
Targanta Antibiotic Shown Effective in Less-Frequent Dose	Luke Timmerman	09/02/08	Boston
Page 1 of 1